Evidence map›Paper›PMID 32384767›Full record

ArticleMolecules (Basel, Switzerland)2020

Multi-Targeting Bioactive Compounds Extracted from Essential Oils as Kinase Inhibitors.

Annalisa Maruca, Delia Lanzillotta, Roberta Rocca, Antonio Lupia, Giosuè Costa, Raffaella Catalano, Federica Moraca, Eugenio Gaudio, Francesco Ortuso, Anna Artese and 2 more

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
1.7field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. In Silico Food-Drug Interaction: A Case Study of Eluxadoline and Fatty Meal.International journal of molecular sciences · 2020
    Article
  9. Article
  10. Article
  11. Article
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 2 institutions in 2 countries.

Annalisa MarucaDipartimento di Scienze della Salute, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0002-6537-552X
Delia LanzillottaDepartment of Experimental and Clinical Medicine, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0001-6439-3876
Roberta RoccaNet4Science srl, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0002-0680-7097
Antonio LupiaNet4Science srl, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.
Giosuè CostaDipartimento di Scienze della Salute, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.ORCID 0000-0003-0947-9479
Raffaella CatalanoDipartimento di Scienze della Salute, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.
Federica MoracaNet4Science srl, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.
Eugenio GaudioLymphoma and Genomics Research Program, the Institute of Oncology Research, 6500 Bellinzona, Switzerland.
Francesco OrtusoDipartimento di Scienze della Salute, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.
Anna ArteseDipartimento di Scienze della Salute, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.
Francesco TrapassoDepartment of Experimental and Clinical Medicine, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.
Stefano AlcaroDipartimento di Scienze della Salute, Università "Magna Græcia" di Catanzaro, Campus Universitario "S. Venuta", Viale Europa, Loc. Germaneto, 88100 Catanzaro, Italy.
Magna Graecia University · ITInstitute of Oncology Research · CH

Funding

European Cooperation in Science and Technology CA15135Ministero dell'Istruzione, dell'Università e della Ricerca NUTRAMED PON 03PE000_78_2Ministero dell'Istruzione, dell'Università e della Ricerca PRIN 201744BN5TRegione Campania B61C17000070007
6 · The paper itself

Abstract

Essential oils (EOs) are popular in aromatherapy, a branch of alternative medicine that claims their curative effects. Moreover, several studies reported EOs as potential anti-cancer agents by inducing apoptosis in different cancer cell models. In this study, we have considered EOs as a potential resource of new kinase inhibitors with a polypharmacological profile. On the other hand, computational methods offer the possibility to predict the theoretical activity profile of ligands, discovering dangerous off-targets and/or synergistic effects due to the potential multi-target action. With this aim, we performed a Structure-Based Virtual Screening (SBVS) against X-ray models of several protein kinases selected from the Protein Data Bank (PDB) by using a chemoinformatics database of EOs. By evaluating theoretical binding affinity, 13 molecules were detected among EOs as new potential kinase inhibitors with a multi-target profile. The two compounds with higher percentages in the EOs were studied more in depth by means Induced Fit Docking (IFD) protocol, in order to better predict their binding modes taking into account also structural changes in the receptor. Finally, given its good binding affinity towards five different kinases, cinnamyl cinnamate was biologically tested on different cell lines with the aim to verify the antiproliferative activity. Thus, this work represents a starting point for the optimization of the most promising EOs structure as kinase inhibitors with multi-target features.

Indexed as

Antineoplastic AgentsCell Line, TumorCell SurvivalCinnamatesErbB ReceptorsHumansLigandsMolecular Docking SimulationOils, VolatilePolypharmacologyProtein Kinase InhibitorsProtein KinasesProtein-Tyrosine KinasesProto-Oncogene Proteins B-rafPyruvate Dehydrogenase Acetyl-Transferring KinaseReceptor Protein-Tyrosine KinasesAntineoplastic AgentsBMX protein, humanBRAF protein, humanCinnamatesEGFR protein, humanErbB ReceptorsLigandsOils, VolatilePDK1 protein, humanProtein Kinase InhibitorsProtein KinasesProtein-Tyrosine KinasesProto-Oncogene Proteins B-rafPyruvate Dehydrogenase Acetyl-Transferring KinaseReceptor Protein-Tyrosine KinasesRON proteinanti-canceressential oilskinasesmulti-targetpolypharmacologySBVS

Identifiers

PMID32384767
PMCPMC7249159
OpenAlexW3023665922

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.